Community denosumab service for osteoporosis patients in Lambeth.
NHS South East London Integrated Care Board seeks a provider for a community-based shared care service administering denosumab 60mg/ml for osteoporosis. The service covers patients in Lambeth or registered with a Lambeth GP, identified by secondary care as suitable for community treatment. The provider will handle blood monitoring, prescribing support, and timely injection administration per the South East London Shared Care Agreement, while clinical responsibility stays with secondary care. The contract likely involves ongoing patient management and coordination with secondary care.